TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IDYA

Ideaya Biosciences Inc

Healthcare · Biotechnology

38.20$ +4.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IDYA
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
77.7% 93.9% 90.0% 96.8% 65.8% 95.5% 82.0% 61.4% 60.1%
34.1% 21.2% 30.1% 24.2% 24.1% 17.7% 24.2% 7.5% 10.2%
75.3% 93.2% 87.6% 95.1% 64.7% 94.0% 80.9% 60.2% 57.6%
– – – 0.6% 0.3% 0.1% 0.0% 0.0% 0.5%
0.0% 0.0% – – -31.8% -2.1% 82.0% – –
21.4% 5.3% 8.6% 3.2% 1.2% 1.7% – – –
0.0% 0.0% – – – – – – –
0.0% 0.0% – – – – – – –
190.0% 150.7% 11.2% 33.5% 20.9% 9.9% 4.3% 5.8% 7.8%
13.9% 5.6% 6.1% 13.0% 11.8% 8.2% 4.2% 4.1% 5.3%
0.0% 0.0% 1.0% 0.5% 0.4% 0.5% 0.3% 0.0% 0.0%
3.8% 1.5% 0.6% 0.3% 0.6% 1.1% 1.0% 1.4% 1.6%
18.3% 0.0% – – – – – – –
-90.0% -50.7% 88.8% 66.5% 79.1% 90.1% 95.7% 94.2% 92.2%
-92.5% -52.3% -81.8% -42.6% -46.3% -60.7% -53.7% -55.4% -66.4%
81.5% 14.8% 17.9% 8.3% 9.2% 10.7% 8.9% 7.3% 8.0%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?